Alto Neuroscience Announces Additional Funding of $60 Million
– New investor Alpha Wave Ventures has invested $25 million as part of Series B, extending the operating runway until 2025. – – Alto entered into a $35 million credit facility with K2 HealthVentures – – The company is now funded through four placebo-controlled phase 2 studies with four different product candidates for three different …
Alto Neuroscience Announces Additional Funding of $60 Million Read More »